Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP540893.RA-yyK8RfaejDky-pGuTQy3H8fSSifDWM9VF7zAjEEHAc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP540893.RA-yyK8RfaejDky-pGuTQy3H8fSSifDWM9VF7zAjEEHAc130_assertion type Assertion NP540893.RA-yyK8RfaejDky-pGuTQy3H8fSSifDWM9VF7zAjEEHAc130_head.
- NP540893.RA-yyK8RfaejDky-pGuTQy3H8fSSifDWM9VF7zAjEEHAc130_assertion description "[There were no significant differences in these parameters between patients treated with IM or oral vitamin E. PBMCs of HD patients showed enhanced membrane lipid peroxidation and release of LTB(4), both linked to upregulation of 5-LOX: 5-Lox activity and related oxidative stress were significantly (although not completely) suppressed by vitamin E regardless of the administration route.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP540893.RA-yyK8RfaejDky-pGuTQy3H8fSSifDWM9VF7zAjEEHAc130_provenance.
- NP540893.RA-yyK8RfaejDky-pGuTQy3H8fSSifDWM9VF7zAjEEHAc130_assertion evidence source_evidence_literature NP540893.RA-yyK8RfaejDky-pGuTQy3H8fSSifDWM9VF7zAjEEHAc130_provenance.
- NP540893.RA-yyK8RfaejDky-pGuTQy3H8fSSifDWM9VF7zAjEEHAc130_assertion SIO_000772 11325678 NP540893.RA-yyK8RfaejDky-pGuTQy3H8fSSifDWM9VF7zAjEEHAc130_provenance.
- NP540893.RA-yyK8RfaejDky-pGuTQy3H8fSSifDWM9VF7zAjEEHAc130_assertion wasDerivedFrom befree-20150227 NP540893.RA-yyK8RfaejDky-pGuTQy3H8fSSifDWM9VF7zAjEEHAc130_provenance.
- NP540893.RA-yyK8RfaejDky-pGuTQy3H8fSSifDWM9VF7zAjEEHAc130_assertion wasGeneratedBy ECO_0000203 NP540893.RA-yyK8RfaejDky-pGuTQy3H8fSSifDWM9VF7zAjEEHAc130_provenance.